Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$7.53 USD
-0.58 (-7.15%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $7.26 -0.27 (-3.59%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO11/11/24 |
---|---|
Current Quarter | -1.40 |
EPS Last Quarter | -1.77 |
Last EPS Surprise | -2,428.57% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 9.80 |
Next Year | -5.60 |
EPS (TTM) | -11.27 |
P/E (F1) | 0.77 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.13M | 0.18M | 0.72M | 0.94M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.13M | 0.18M | 0.72M | 0.94M |
Low Estimate | 0.13M | 0.18M | 0.72M | 0.94M |
Year ago Sales | 0.37M | 0.21M | 1.83M | 0.72M |
Year over Year Growth Est. | -64.86% | -14.29% | -60.55% | 30.56% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.40 | -1.40 | 9.80 | -5.60 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | 9.80 | -5.60 |
High Estimate | -1.40 | -1.40 | 9.80 | -5.60 |
Low Estimate | -1.40 | -1.40 | 9.80 | -5.60 |
Year ago EPS | -4.07 | -4.06 | -18.70 | 9.80 |
Year over Year Growth Est. | 65.60% | 65.52% | 152.41% | -157.14% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.40 | -1.40 | 9.80 | -5.60 |
7 Days Ago | -1.40 | -1.40 | 9.80 | -5.60 |
30 Days Ago | -1.40 | -1.40 | 9.80 | -5.60 |
60 Days Ago | -1.40 | -1.40 | -7.20 | -7.20 |
90 Days Ago | -1.40 | -1.40 | -6.80 | -6.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.40 | -1.40 | 9.80 | -5.60 |
Zacks Consensus Estimate | -1.40 | -1.40 | 9.80 | -5.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.77 | -1.37 | -4.06 | -4.07 | NA |
Estimate | -0.07 | NA | NA | -4.00 | NA |
Difference | -1.70 | NA | NA | -0.07 | -0.89 |
Surprise | -2,428.57% | NA | NA | -1.75% | -1,215.16% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more